RemeGen.
$0.000000
3
+$0.00+0%Monday 00:00
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Oct 29Expected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q3 2026
-0.08
0
0.08
0.16
Expected EPS
N/A
Actual EPS
0.1608444
Financials
12.91%Profit Margin
Profitable527.81MRevenue
68.17MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
RemeGen Co., Ltd., a biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States. The company offers Telitacicept (RC18) for the treatment of systemic lupus erythematosus (SLE) autoimmune disease, rheumatoid arthritis, and myasthenia gravis; and Disitamab Vedotin (RC48), an antibody drug conjugate for the treatment of gastric cancer, urothelial carcinoma, breast cancer, and other tumors. It also develops products in various stages, including RC-28E, a fusion protein that targets vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF); RC88, an antibody-drug conjugate (ADC) that targets mesothelin; and RC148, a bispecific antibody ADC drug that in Phase1/2 clinical studies targeting program cell death protein 1 (PD-1) and VEGF; RC278, an ADC drug for the treatment of multiple solid tumors; and RC288, a dual-antibody ADC drug for the treatment of various tumors. The company was founded in 2008 and is headquartered in Yantai, the People's Republic of China.
Show More
CEO
Jian Min Fang
Employees
3048
Country
China
ISIN
US75956A1034
Listings
0 Comments
Share your thoughts
FAQs
What is RemeGen. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange RemeGen. stocks are traded under the ticker REGMY.
When is the next RemeGen. earnings date?▼
RemeGen. is going to release the next earnings report on March 31, 2027.
What were RemeGen. earnings last quarter?▼
REGMY earnings for the last quarter are 0.16 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is RemeGen. revenue for the last year?▼
RemeGen. revenue for the last year amounts to 527.81M USD.
What is RemeGen. net income for the last year?▼
REGMY net income for the last year is 68.17M USD.
How many employees does RemeGen. have?▼
As of November 8, 2026, the company has 3,048 employees.
In which sector is RemeGen. located?▼
RemeGen. operates in the Health & Wellness sector.
When did RemeGen. complete a stock split?▼
RemeGen. has not had any recent stock splits.
Where is RemeGen. headquartered?▼
RemeGen. is headquartered in Yantai, China.